Spevigo 150 mg/mL prefilled syringe Images

Generic Name: spesolimab

This medication has been identified as Spevigo 150 mg/mL prefilled syringe. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.

Spevigo is used in the treatment of Generalized Pustular Psoriasis and belongs to the drug class interleukin inhibitors. Spevigo 150 mg/mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Spevigo

Generic Name

spesolimab

Strength

150 mg/mL prefilled syringe

Availability

Prescription only

Drug Class

Interleukin inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

Boehringer Ingelheim Pharmaceuticals, Inc.

National Drug Code (NDC)

00597-0620

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer